Now more than ever, it matters where data and information informing drug development strategy and practices comes from.  Tufts CSDD is a uniquely positioned, objective, influential and authoritative source.

We are the only independent, multi-disciplinary academic research center dedicated to, and known for robust, data-driven, and evidence-based assessment, analysis, and insight on trends and practices impacting global clinical trial planning and execution.

As an independent academic group, Tufts CSDD is self-supported. Yet, we also rely on sponsorship and support from drug development professionals to help cover operating expenses and to support our mission.

Founded in 1976, Tufts CSDD research has been frequently cited and utilized by regulatory authorities, government entities, private sector companies, professional societies and associations, and academic leaders worldwide. Our reputation for scholarship and independence allows us to bring together and collaborate with stakeholders throughout the diverse global drug development community. It is also why the U.S. Congress, regulatory bodies in the U.S. and abroad, and the multinational drug industry rely on our research findings to understand the demands of pharmaceutical innovation and to inform policy decisions and organization strategies.